Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2022

Open Access 07-08-2021 | Gastrointestinal Bleeding | Original Article

Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding

Authors: K. Siebenhüner, J. Blaser, A. Nowak, M. Cheetham, B. U. Mueller, E. Battegay, P. E. Beeler

Published in: Digestive Diseases and Sciences | Issue 8/2022

Login to get access

Abstract

Background

Multimorbidity increases healthcare resource utilization. Little is known on specific comorbidity combinations.

Aims

To identify comorbidities associated with increased resource utilization among inpatients admitted for gastrointestinal bleeding (GIB).

Methods

This retrospective cross-sectional study, 1/2010–5/2018 at the University Hospital Zurich, Switzerland, analyzed electronic health records of patients with upper (UGIB) and lower (LGIB) GIB, focusing on length of stay (LOS) and 30-day readmissions for resource use and clinical outcomes, investigated by multivariable regression adjusted for antithrombotics.

Results

Of 1101 patients, 791 had UGIB and 310 LGIB, most often melena and bleeding diverticula, respectively. In UGIB, thromboembolic events showed a trend toward 27% increased LOS (1.27; 95% confidence interval [CI] 1.00–1.61), antithrombotics independently associated with 46% increased LOS (1.46; 95% CI 1.32–1.62). Cancer (odds ratio [OR] 2.86; 95% CI 1.68–4.88) independently associated with 30-day readmissions, anemia showed a trend (OR 1.68; 95% CI 1.00–2.84). In LGIB, none of the investigated comorbidities associated with increased LOS, but antithrombotics independently associated with 25% increased LOS (1.25; 95% CI 1.07–1.46). Atrial fibrillation/flutter (OR 2.69; 95% CI 1.06–6.82) and cancer (OR 4.76; 95% CI 1.40–16.20) associated strongly with 30-day readmissions.

Conclusions

In both groups, cancer associated with 30-day readmissions, antithrombotics with increased LOS. Thromboembolic events and anemia showed clinically important trends in UGIB. Atrial fibrillation/flutter associated with 30-day readmissions in LGIB. Prospective studies are needed to investigate these complex multimorbid populations and establish appropriate guidelines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M et al. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study. J Gerontol A Biol Sci Med Sci. 2016;71:205–214.CrossRef Garin N, Koyanagi A, Chatterji S, Tyrovolas S, Olaya B, Leonardi M et al. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study. J Gerontol A Biol Sci Med Sci. 2016;71:205–214.CrossRef
2.
go back to reference Marengoni A, Roso-Llorach A, Vetrano DL, Fernandez-Bertolin S, Guisado-Clavero M, Violan C et al. Patterns of multimorbidity in a population-based cohort of older people: sociodemographic, lifestyle, clinical, and functional differences. J Gerontol A Biol Sci Med Sci. 2020;75:798–805.PubMed Marengoni A, Roso-Llorach A, Vetrano DL, Fernandez-Bertolin S, Guisado-Clavero M, Violan C et al. Patterns of multimorbidity in a population-based cohort of older people: sociodemographic, lifestyle, clinical, and functional differences. J Gerontol A Biol Sci Med Sci. 2020;75:798–805.PubMed
3.
go back to reference van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51:367–375.CrossRef van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51:367–375.CrossRef
4.
go back to reference Aubert CE, Schnipper JL, Roumet M, Marques-Vidal P, Stirnemann J, Auerbach AD et al. Best definitions of multimorbidity to identify patients with high health care resource utilization. Mayo Clin Proc Innov Qual Outcomes. 2020;4:40–49.CrossRef Aubert CE, Schnipper JL, Roumet M, Marques-Vidal P, Stirnemann J, Auerbach AD et al. Best definitions of multimorbidity to identify patients with high health care resource utilization. Mayo Clin Proc Innov Qual Outcomes. 2020;4:40–49.CrossRef
5.
go back to reference Battegay E. Multimorbidity is a game changer. Swiss Med Wkly. 2019;149:w20131. Battegay E. Multimorbidity is a game changer. Swiss Med Wkly. 2019;149:w20131.
6.
go back to reference Poblador-Plou B, Calderon-Larranaga A, Marta-Moreno J, Hancco-Saavedra J, Sicras-Mainar A, Soljak M et al. Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry. 2014;14:84.CrossRef Poblador-Plou B, Calderon-Larranaga A, Marta-Moreno J, Hancco-Saavedra J, Sicras-Mainar A, Soljak M et al. Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry. 2014;14:84.CrossRef
8.
go back to reference Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10:142–151.CrossRef Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10:142–151.CrossRef
9.
go back to reference Excoffier S, Herzig L, N'Goran AA, Deruaz-Luyet A, Haller DM. Prevalence of multimorbidity in general practice: a cross-sectional study within the Swiss Sentinel Surveillance System (Sentinella). BMJ Open. 2018;8:e019616. Excoffier S, Herzig L, N'Goran AA, Deruaz-Luyet A, Haller DM. Prevalence of multimorbidity in general practice: a cross-sectional study within the Swiss Sentinel Surveillance System (Sentinella). BMJ Open. 2018;8:e019616.
10.
go back to reference Kowal P, Arokiasamy P, Afshar S, Pati S, Snodgrass JJ. Multimorbidity: health care that counts “past one” for 1.2 billion older adults. Lancet. 2015;385:2252–2253. Kowal P, Arokiasamy P, Afshar S, Pati S, Snodgrass JJ. Multimorbidity: health care that counts “past one” for 1.2 billion older adults. Lancet. 2015;385:2252–2253.
11.
go back to reference Tanne JH, Hayasaki E, Zastrow M, Pulla P, Smith P, Rada AG. Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide. BMJ. 2020;368:m1090. Tanne JH, Hayasaki E, Zastrow M, Pulla P, Smith P, Rada AG. Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide. BMJ. 2020;368:m1090.
12.
go back to reference Beeler PE, Cheetham M, Held U, Battegay E. Depression is independently associated with increased length of stay and readmissions in multimorbid inpatients. Eur J Intern Med. 2020;73:59–66.CrossRef Beeler PE, Cheetham M, Held U, Battegay E. Depression is independently associated with increased length of stay and readmissions in multimorbid inpatients. Eur J Intern Med. 2020;73:59–66.CrossRef
14.
go back to reference Strate LL. Lower GI bleeding: epidemiology and diagnosis. Gastroenterol Clin North Am. 2005;34:643–664.CrossRef Strate LL. Lower GI bleeding: epidemiology and diagnosis. Gastroenterol Clin North Am. 2005;34:643–664.CrossRef
15.
go back to reference Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ. 2019;364:l536. Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ. 2019;364:l536.
16.
go back to reference Fearnhead N. Acute lower gastrointestinal bleeding. Medicine. 2015;43. Fearnhead N. Acute lower gastrointestinal bleeding. Medicine. 2015;43.
17.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.
18.
go back to reference Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ. 1995;311:222–226. Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ. 1995;311:222–226.
19.
go back to reference Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138:1093–1100.CrossRef Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138:1093–1100.CrossRef
20.
go back to reference Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–272.CrossRef Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–272.CrossRef
21.
go back to reference Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.CrossRef Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.CrossRef
22.
go back to reference Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43.CrossRef Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43.CrossRef
23.
go back to reference Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50:1109–1118.CrossRef Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50:1109–1118.CrossRef
24.
go back to reference van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22:209–224.CrossRef van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22:209–224.CrossRef
25.
go back to reference Oakland K. Changing epidemiology and etiology of upper and lower gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2019;42–43:101610. Oakland K. Changing epidemiology and etiology of upper and lower gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2019;42–43:101610.
26.
go back to reference Battegay E, Cheetham M, Holzer BM, Nowak A, Schmidt D, Rampini S. Multimorbidity management and the physician’s daily clinical dilemma. Internist (Berl). 2017;58:344–353.CrossRef Battegay E, Cheetham M, Holzer BM, Nowak A, Schmidt D, Rampini S. Multimorbidity management and the physician’s daily clinical dilemma. Internist (Berl). 2017;58:344–353.CrossRef
27.
go back to reference Markun S, Holzer BM, Rodak R, Kaplan V, Wagner CC, Battegay E, et al. Therapeutic conflicts in emergency department patients with multimorbidity: a cross-sectional study. PLoS One. 2014;9:e110309. Markun S, Holzer BM, Rodak R, Kaplan V, Wagner CC, Battegay E, et al. Therapeutic conflicts in emergency department patients with multimorbidity: a cross-sectional study. PLoS One. 2014;9:e110309.
28.
go back to reference Schizas D, Kariori M, Boudoulas KD, Siasos G, Patelis N, Kalantzis C et al. Management of antithrombotic therapy in patients with coronary artery disease or atrial fibrillation who underwent abdominal surgical operations. Curr Pharm Des. 2018;24:2743–2755.CrossRef Schizas D, Kariori M, Boudoulas KD, Siasos G, Patelis N, Kalantzis C et al. Management of antithrombotic therapy in patients with coronary artery disease or atrial fibrillation who underwent abdominal surgical operations. Curr Pharm Des. 2018;24:2743–2755.CrossRef
29.
go back to reference Jansen P, Götz M. Trebicka J [S2k-Leitlinie Gastrointestinale Blutung. AWMF-Register Nr. 021–028]. Z Gastroenterol 2017;55:937–946.CrossRef Jansen P, Götz M. Trebicka J [S2k-Leitlinie Gastrointestinale Blutung. AWMF-Register Nr. 021–028]. Z Gastroenterol 2017;55:937–946.CrossRef
30.
go back to reference Apostolakis S, Lane DA, Buller H, Lip GY. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Thromb Haemost. 2013;110:1074–1079.CrossRef Apostolakis S, Lane DA, Buller H, Lip GY. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Thromb Haemost. 2013;110:1074–1079.CrossRef
31.
go back to reference Garcia DA, Fisher DA, Mulder H, Wruck L, De Caterina R, Halvorsen S et al. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2020;221:1–8.CrossRef Garcia DA, Fisher DA, Mulder H, Wruck L, De Caterina R, Halvorsen S et al. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2020;221:1–8.CrossRef
32.
go back to reference Amin AN, Robinson SB, Bowdy BD, Jing Y, Johnson BH, Wiederkehr DP. Relationship of hospital-associated bleeding with length of stay and total hospitalization costs in patients hospitalized for atrial fibrillation. J Med Econ. 2016;19:490–496.CrossRef Amin AN, Robinson SB, Bowdy BD, Jing Y, Johnson BH, Wiederkehr DP. Relationship of hospital-associated bleeding with length of stay and total hospitalization costs in patients hospitalized for atrial fibrillation. J Med Econ. 2016;19:490–496.CrossRef
33.
go back to reference Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9:e102149. Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9:e102149.
34.
go back to reference Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74:1215–1224.CrossRef Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74:1215–1224.CrossRef
35.
go back to reference Whelan CT, Chen C, Kaboli P, Siddique J, Prochaska M, Meltzer DO. Upper versus lower gastrointestinal bleeding: a direct comparison of clinical presentation, outcomes, and resource utilization. J Hosp Med. 2010;5:141–147.CrossRef Whelan CT, Chen C, Kaboli P, Siddique J, Prochaska M, Meltzer DO. Upper versus lower gastrointestinal bleeding: a direct comparison of clinical presentation, outcomes, and resource utilization. J Hosp Med. 2010;5:141–147.CrossRef
36.
go back to reference Di Nisio M, Candeloro M, Rutjes AWS, Galli V, Tritto M, Porreca E. Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness. Thromb Res. 2018;169:44–49.CrossRef Di Nisio M, Candeloro M, Rutjes AWS, Galli V, Tritto M, Porreca E. Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness. Thromb Res. 2018;169:44–49.CrossRef
37.
go back to reference Saitz R, Ghali WA, Moskowitz MA. The impact of leaving against medical advice on hospital resource utilization. J Gen Intern Med. 2000;15:103–107.CrossRef Saitz R, Ghali WA, Moskowitz MA. The impact of leaving against medical advice on hospital resource utilization. J Gen Intern Med. 2000;15:103–107.CrossRef
38.
go back to reference Gili-Miner M, Bejar-Prado L, Gili-Ortiz E, Ramirez-Ramirez G, Lopez-Mendez J, Lopez-Millan JM et al. Alcohol use disorders among surgical patients: unplanned 30-days readmissions, length of hospital stay, excessive costs and mortality. Drug Alcohol Depend. 2014;137:55–61.CrossRef Gili-Miner M, Bejar-Prado L, Gili-Ortiz E, Ramirez-Ramirez G, Lopez-Mendez J, Lopez-Millan JM et al. Alcohol use disorders among surgical patients: unplanned 30-days readmissions, length of hospital stay, excessive costs and mortality. Drug Alcohol Depend. 2014;137:55–61.CrossRef
39.
go back to reference Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am. 1996;80:1035–1068.CrossRef Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am. 1996;80:1035–1068.CrossRef
40.
go back to reference Buurman BM, Frenkel WJ, Abu-Hanna A, Parlevliet JL, de Rooij SE. Acute and chronic diseases as part of multimorbidity in acutely hospitalized older patients. Eur J Intern Med. 2016;27:68–75.CrossRef Buurman BM, Frenkel WJ, Abu-Hanna A, Parlevliet JL, de Rooij SE. Acute and chronic diseases as part of multimorbidity in acutely hospitalized older patients. Eur J Intern Med. 2016;27:68–75.CrossRef
41.
go back to reference Wasse H, Gillen DL, Ball AM, Kestenbaum BR, Seliger SL, Sherrard D et al. Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int. 2003;64:1455–1461.CrossRef Wasse H, Gillen DL, Ball AM, Kestenbaum BR, Seliger SL, Sherrard D et al. Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int. 2003;64:1455–1461.CrossRef
43.
go back to reference Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P et al. Systematic review of discharge coding accuracy. J Public Health (Oxf). 2012;34:138–148.CrossRef Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P et al. Systematic review of discharge coding accuracy. J Public Health (Oxf). 2012;34:138–148.CrossRef
44.
go back to reference Joos C, Lawrence K, Jones AE, Johnson SA, Witt DM. Accuracy of ICD-10 codes for identifying hospitalizations for acute anticoagulation therapy-related bleeding events. Thromb Res. 2019;181:71–76.CrossRef Joos C, Lawrence K, Jones AE, Johnson SA, Witt DM. Accuracy of ICD-10 codes for identifying hospitalizations for acute anticoagulation therapy-related bleeding events. Thromb Res. 2019;181:71–76.CrossRef
45.
go back to reference Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7:512–514.CrossRef Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7:512–514.CrossRef
46.
go back to reference Lattanzi B, Gioia S, Di Cola S, D’Ambrosio D, Nardelli S, Tavano D et al. Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension. Liver Int. 2019;39:1937–1942.CrossRef Lattanzi B, Gioia S, Di Cola S, D’Ambrosio D, Nardelli S, Tavano D et al. Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension. Liver Int. 2019;39:1937–1942.CrossRef
Metadata
Title
Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding
Authors
K. Siebenhüner
J. Blaser
A. Nowak
M. Cheetham
B. U. Mueller
E. Battegay
P. E. Beeler
Publication date
07-08-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07197-7

Other articles of this Issue 8/2022

Digestive Diseases and Sciences 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.